Carbohydrate-based vaccine combats Staphylococcus aureus
In animal studies, the new vaccine construct outperformed another PNAG-vaccine delivery system currently in human trials.
List view / Grid view
In animal studies, the new vaccine construct outperformed another PNAG-vaccine delivery system currently in human trials.
Researchers have found what triggers bacteria to start the CBASS immune response to counter infections by phages.
Swedish study reveals a significant link between specific gut bacteria and the development of coronary atherosclerotic plaques, a leading cause of heart attacks.
US researchers find that recurrent bouts of systemic lupus erythematosus is closely tracked with measurable upticks in growth in the gut of a certain species of bacteria.
An increasing number of people worldwide suffer from inflammatory bowel disease (IBD). However, no treatment is effective for all patients. In this article, researchers working on the Algae4IBD project explain how algae may represent a valuable source of prebiotics and new therapeutic agents for IBD and other diseases.
The drug resistant bacteria: CRAB, came into the ICU in hospitals in Hangzhou, China, creating an urgent need for a thorough understanding of the persistence, transmission, and evolution of CRAB populations in such environments.
Australian scientists explored a group of bacterial pathogens that share a protein sequence which is recognised by human T cells.
US scientists have developed antibiotics that can “shape-shift”, which prevent bacteria from coming resistant against them.
This article outlines new research from the University of Pennsylvania, concerning Yersinia pseudotuberculosis, a relative of the bacterial pathogen that causes plague by triggering the body’s immune system to form lesions in the intestines.
US researchers investigate how bacteria develop an antibiotic tolerance without mutations.
A study has shown that the ES17 phage binds to heparan sulphate and can target and eliminate ExPEC bacteria in animal models.
New research has shown that 'hidden' lysis genes in bacteriophages could be used in the development of a new class of antibiotics.
The role that retrons in bacteria has been discovered by researchers, who found they protect colonies when infected by viruses.
A group of scientists has created a novel high-throughput hit-to-lead development platform to identify engineered antibacterial lysins.
The novel CRISPR-CasΦ enzyme, isolated from bacteriophages, can target a wider range of genetic sequences, say the researchers.